Sordarins: In Vitro Activities of New Antifungal Derivatives against Pathogenic Yeasts, <i>Pneumocystis carinii</i> , and Filamentous Fungi
Esperanza Herreros(GlaxoSmithKline (Spain)), Domingo Gargallo‐Viola(GlaxoSmithKline (United Kingdom)), M. S. Marriott(GlaxoSmithKline (Italy)), F. G. DE LAS HERAS, María Jesús Almela, C. M. Martinez
Cited by 88
Related Papers
Improved Murine Model of Malaria Using<i>Plasmodium falciparum</i>Competent Strains and Non-Myelodepleted NOD-<i>scid IL2R</i>γ<sup><i>null</i></sup>Mice Engrafted with Human Erythrocytes
|Antimicrobial Agents and Chemotherapy|2009|189
A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes
|PLoS ONE|2008|164
Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials
|Journal of Medicinal Chemistry|2008|139
Transmission of Pneumocystis carinii Disease from Immunocompetent Contacts of Infected Hosts to Susceptible Hosts
|European Journal of Clinical Microbiology & Infectious Diseases|2000|134
Anticoagulants Interfere with PCR Used To Diagnose Invasive Aspergillosis
|Journal of Clinical Microbiology|2002|122